Host susceptibility and clinical outcomes in toll-like receptor 5–deficient patients with typhoid fever in Vietnam

Dunstan, Sarah J., Hawn, Thomas R., Hue, Nguyen Thi, Parry, Christopher P., Ho, Vo An, Vinh, Ha, Diep, To Song, House, Deborah, Wain, John, Aderem, Alan, Hien, Tran Tinh and Farrar, Jeremy J. (2005) Host susceptibility and clinical outcomes in toll-like receptor 5–deficient patients with typhoid fever in Vietnam. Journal of Infectious Diseases, 191 (7). pp. 1068-1071. ISSN 0022-1899

Full text not available from this repository. (Request a copy)

Abstract

Toll-like receptor 5 (TLR5) mediates innate immune responses to bacterial pathogens by binding to flagellin. A polymorphism in the TLR5 gene introduces a premature stop codon (TLR5392STOP) that is associated with susceptibility to legionnaires disease. Here we investigated whether TLR5392STOP was associated with typhoid fever. The frequency of TLR5392STOP was not significantly different in 565 patients with typhoid fever and 281 ethnically matched control subjects. Furthermore, TLR5 deficiency had no measurable effect on a number of clinical parameters associated with typhoid fever, including fever clearance time, pathogen burden, disease severity, or age at acquisition of disease. TLR5 may not play an important role in TLR-stimulated innate immune responses to human infection with Salmonella enterica serovar Typhi. Initiation of these responses may rely on other TLRs that recognize different bacterial ligands

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Medical Microbiology (former - to 2018)
Depositing User: Rhiannon Harvey
Date Deposited: 12 Jul 2011 11:07
Last Modified: 21 Dec 2023 01:35
URI: https://ueaeprints.uea.ac.uk/id/eprint/33540
DOI: 10.1086/428593

Actions (login required)

View Item View Item